EVERSANA was a proud sponsor of the 2020 virtual edition of World Orphan Drug Congress USA. This year’s event featured over 260 presentations covering all aspects of orphan drug development and rare disease research.
As dedicated advocates of the rare disease community, EVERSANA is on a mission to advance the commercialization of orphan drugs and improve patient outcomes.
Click the links below to watch the full sessions our team of experts presented at WODC.
MONDAY, AUGUST 24
Oodaye Shukla, Chief Data Officer, EVERSANA
- Presentation: Examining industry strategies for leveraging patient data and AI to advance rare disease patient identification, R&D, and commercialization
- Panel Moderator: Transforming rare disease drug discovery models through open science and artificial intelligence
- Keynote Panel: Examining industry strategies for leveraging patient data and AI to advance rare disease patient identification, R&D, and commercialization
WEDNESDAY, AUGUST 26
Jim Lang, CEO, EVERSANA
- 10:35 AM EST
Keynote Fireside Chat Moderator: Industry perspective on value and access strategies – developing a cohesive agenda and unified framework for orphan drugs
THURSDAY, AUGUST 27
Chris Cameron, PhD, SVP – Value and Evidence, EVERSANA
- 12:40 PM EST
Presentation: Developing and implementing HEOR programs to support global HTA and reimbursement decisions involving orphan products
- 1:00 PM EST
Panel: Use of real-world evidence in HTA review of orphan products
Click here to schedule a meeting with our team of experts.